Get the Stockscreener App
0.78
3.22%
0.0243
After Hours:
.81
0.03
+3.85%
Kala Bio Inc stock is traded at $0.78, with a volume of 144.83K.
It is up +3.22% in the last 24 hours and down -49.02% over the past month.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
See More
Previous Close:
$0.7557
Open:
$0.75
24h Volume:
144.83K
Relative Volume:
0.14
Market Cap:
$5.48M
Revenue:
$5.75M
Net Income/Loss:
$-38.96M
P/E Ratio:
-0.0626
EPS:
-12.47
Net Cash Flow:
$-32.63M
1W Performance:
-2.00%
1M Performance:
-49.02%
6M Performance:
-80.35%
1Y Performance:
-88.92%
1-Day Range:
$0.74
$0.801
1-Week Range:
$0.74
$0.833
52-Week Range:
$0.74
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Name
Kala Bio Inc
Sector
Industry
Phone
781-996-5252
Address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Compare KALA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.78 | 5.31M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Downgrade | Mizuho | Outperform → Neutral |
| Sep-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-29-25 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-08-25 | Initiated | Mizuho | Outperform |
| Jul-11-25 | Initiated | Ladenburg Thalmann | Buy |
| Mar-30-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-14-20 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-20 | Initiated | Northland Capital | Outperform |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| May-27-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-17-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-14-19 | Initiated | Jefferies | Buy |
View All
Kala Bio Inc Stock (KALA) Latest News
Real time scanner hits for KALA BIO Inc. explained2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Applying Elliott Wave Theory to KALA BIO Inc.Market Growth Review & Low Drawdown Investment Ideas - newser.com
Will KALA BIO Inc. stock sustain high P E ratiosGap Up & Consistent Profit Focused Trading Strategies - newser.com
Will KALA BIO Inc. outperform the marketJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Is KALA BIO Inc. stock a contrarian buyJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
Real time alert setup for KALA BIO Inc. performanceJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
When is the best time to exit KALA BIO Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
How hedge fund analytics apply to KALA BIO Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com
What drives KALA BIO Inc stock priceUtilities Sector Analysis & Rapid Portfolio Expansion - earlytimes.in
Is KALA BIO Inc a good long term investmentCash Flow Trends & Identify Breakout Stocks - earlytimes.in
Chart based exit strategy for KALA BIO Inc.July 2025 Snapshot & Safe Capital Investment Plans - newser.com
How supply chain issues affect KALA BIO Inc. stock2025 Support & Resistance & Weekly Momentum Picks - newser.com
KALA BIO Inc. stock trend outlook and recovery pathJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Will KALA BIO Inc. stock deliver shareholder value2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Applying big data sentiment scoring on KALA BIO Inc.Weekly Investment Report & Fast Momentum Entry Tips - newser.com
Is KALA BIO Inc. stock trading at a premium valuationMarket Risk Report & Verified Technical Trade Signals - newser.com
A Heavy Trading Day Sends Biotech And Finance Stocks Reeling - Finimize
Will KALA BIO Inc. stock outperform value stocks2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Using fundamentals and technicals on KALA BIO Inc.Weekly Market Outlook & Low Risk High Win Rate Stock Picks - newser.com
Volatility clustering patterns for KALA BIO Inc.M&A Rumor & AI Optimized Trade Strategies - newser.com
Measuring KALA BIO Inc.’s beta against major indicesQuarterly Trade Review & Growth Focused Entry Reports - newser.com
Will KALA BIO Inc. stock recover after recent dropJuly 2025 EndofMonth & Fast Exit and Entry Strategy Plans - newser.com
Detecting support and resistance levels for KALA BIO Inc.Earnings Trend Report & High Conviction Investment Ideas - newser.com
Risk vs reward if holding onto KALA BIO Inc.July 2025 EndofMonth & Capital Protection Trading Alerts - newser.com
Why KALA BIO Inc. stock is recommended by analystsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Published on: 2025-10-28 16:54:10 - fcp.pa.gov.br
Kala Bio Inc Stock (KALA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):